Chemoinformaics analysis of 1,4,7-Trihydroxy-5-methoxyfluoren-9-one
| Molecular Weight | 258.229 | nRot | 1 |
| Heavy Atom Molecular Weight | 248.149 | nRig | 16 |
| Exact Molecular Weight | 258.053 | nRing | 3 |
| Solubility: LogS | -5.219 | nHRing | 0 |
| Solubility: LogP | 2.96 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 34.0579 |
| nHD | 3 | BPOL | 12.6361 |
| QED | 0.581 |
| Synth | 2.446 |
| Natural Product Likeliness | 1.626 |
| NR-PPAR-gamma | 0.802 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.008 |
| HIA | 0.019 |
| CACO-2 | -4.983 |
| MDCK | 0.00000986 |
| BBB | 0.029 |
| PPB | 0.973 |
| VDSS | 0.559 |
| FU | 0.0296 |
| CYP1A2-inh | 0.864 |
| CYP1A2-sub | 0.741 |
| CYP2c19-inh | 0.06 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.348 |
| CYP2c9-sub | 0.821 |
| CYP2d6-inh | 0.302 |
| CYP2d6-sub | 0.521 |
| CYP3a4-inh | 0.574 |
| CYP3a4-sub | 0.153 |
| CL | 12.106 |
| T12 | 0.525 |
| hERG | 0.026 |
| Ames | 0.886 |
| ROA | 0.163 |
| SkinSen | 0.234 |
| Carcinogencity | 0.226 |
| EI | 0.967 |
| Respiratory | 0.113 |
| NR-Aromatase | 0.565 |
| Antiviral | Yes |
| Prediction | 0.703105 |